| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DGX | Common Stock | Award | $381,331 | +2,579 | +24% | $147.86 | 13,145 | 06 Mar 2023 | Direct | F1 |
| transaction | DGX | Common Stock | Tax liability | $118,140 | -799 | -6.1% | $147.86 | 12,357 | 06 Mar 2023 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d). |
| F2 | Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. |
| F3 | The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. |